ADINOLFI, Luigi Elio
 Distribuzione geografica
Continente #
EU - Europa 14.726
NA - Nord America 10.282
AS - Asia 7.984
SA - Sud America 1.546
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 6
Totale 34.669
Nazione #
US - Stati Uniti d'America 10.141
RU - Federazione Russa 6.023
SG - Singapore 3.091
IE - Irlanda 2.681
CN - Cina 1.827
HK - Hong Kong 1.478
UA - Ucraina 1.410
BR - Brasile 1.338
GB - Regno Unito 1.106
IT - Italia 1.081
DE - Germania 938
SE - Svezia 432
FI - Finlandia 392
VN - Vietnam 360
TR - Turchia 354
KR - Corea 269
GR - Grecia 231
FR - Francia 228
IN - India 195
JP - Giappone 155
AR - Argentina 78
CA - Canada 67
MX - Messico 47
ID - Indonesia 38
EC - Ecuador 37
BD - Bangladesh 36
AT - Austria 33
BE - Belgio 32
NL - Olanda 32
ZA - Sudafrica 31
IQ - Iraq 29
MA - Marocco 23
CO - Colombia 21
EU - Europa 20
RO - Romania 20
IR - Iran 19
PL - Polonia 19
PY - Paraguay 18
CZ - Repubblica Ceca 17
UZ - Uzbekistan 17
CL - Cile 14
PK - Pakistan 13
EG - Egitto 12
UY - Uruguay 12
VE - Venezuela 12
ES - Italia 11
IL - Israele 10
PE - Perù 10
MY - Malesia 9
AE - Emirati Arabi Uniti 7
LT - Lituania 7
NP - Nepal 7
SA - Arabia Saudita 7
TW - Taiwan 7
BG - Bulgaria 6
DZ - Algeria 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KZ - Kazakistan 5
LB - Libano 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
TN - Tunisia 5
CR - Costa Rica 4
JO - Giordania 4
SC - Seychelles 4
AL - Albania 3
AM - Armenia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
HR - Croazia 2
LI - Liechtenstein 2
MD - Moldavia 2
MK - Macedonia 2
SY - Repubblica araba siriana 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AN - Antille olandesi 1
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
Totale 34.653
Città #
Dublin 2.675
Jacksonville 2.125
Moscow 1.883
Santa Clara 1.674
Hong Kong 1.478
Chandler 1.305
Singapore 1.107
Princeton 417
Roxbury 311
Bremen 297
Seoul 265
Ashburn 253
Medford 252
Ann Arbor 218
Boardman 215
New York 214
Beijing 206
Wilmington 193
Hefei 189
The Dalles 186
Woodbridge 186
Cambridge 182
Ho Chi Minh City 129
Bengaluru 128
Dallas 128
San Mateo 124
Nanjing 108
Düsseldorf 102
São Paulo 97
Munich 95
Caserta 94
Des Moines 82
Jinan 74
Mountain View 73
Naples 69
Hanoi 65
Napoli 65
Shenyang 57
Los Angeles 41
Norwalk 41
Nanchang 40
Tianjin 38
Helsinki 37
Rio de Janeiro 36
Zhengzhou 35
Guangzhou 34
Venice 33
Brussels 31
Changsha 31
Nuremberg 30
Shanghai 29
Milan 28
Belo Horizonte 27
Brasília 27
Hangzhou 25
Turku 25
Washington 24
Haikou 23
Houston 23
Campinas 21
Kunming 20
Toronto 20
Haiphong 19
Ningbo 19
Auburn Hills 18
Hebei 18
Da Nang 17
Salvador 17
Taizhou 17
Curitiba 16
Marano Di Napoli 16
Porto Alegre 16
Falkenstein 15
Lanzhou 15
Tokyo 15
Amsterdam 14
Bologna 14
Frankfurt am Main 14
London 14
Tashkent 14
Guarulhos 13
Istanbul 13
Johannesburg 13
Palermo 13
Redwood City 13
Taiyuan 13
Warsaw 13
Baghdad 12
Goiânia 12
Guayaquil 12
Rome 12
Seattle 12
Thái Nguyên 12
Volta Redonda 12
Atlanta 11
Brooklyn 11
Chicago 11
Dearborn 11
Jiaxing 11
Mauá 11
Totale 18.569
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 168
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 158
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 157
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 154
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 150
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 150
Endocardite da Gemella morbillorum: descrizione di due casi 149
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 148
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 147
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 143
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 143
A genic and epigenetic combination therapy for liver cancer 142
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 138
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 135
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 134
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 133
Activity of aminoglycosides against phagocytosed bacteria 131
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 127
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 125
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 124
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 123
Chronic HCV infection and neurological and psychiatric disorders: an overview. 122
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 121
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 121
Sonoporation by microbubbles as gene therapy approach against liver cancer 120
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 119
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 118
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 118
Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department 118
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 117
Acute rhabdomiolisys in healthy woman. 117
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 117
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 116
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 115
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 115
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 114
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 113
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 111
Antimicrobials and biological activities of immune system 110
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 110
Circulating miRNA-195-5p and -451a in Patients with Acute Hemorrhagic Stroke in Emergency Department 109
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 109
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 109
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 108
[Enterococcal endocarditis: clinical and microbiological features of our series] 107
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 107
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 106
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 106
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 105
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 105
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 105
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 104
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 103
Antibiotici 103
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 102
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 101
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 101
effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo e netilmicina 101
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 101
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 101
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 100
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients 100
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 99
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 99
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 99
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 98
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 98
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 98
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 98
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 98
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 98
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 98
Virological patterns of HCV patients with failure to interferon-free regimens. 98
Severe Hyponatremia in the elderly: the seasonalvariability in the emergency department 98
Chronic Hepatitis C Virus Infection and Depression. 98
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. 97
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 97
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 97
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 97
[Effect of levamisole on changes in the of hepatic RES induced by chronic ethanol poisoning] 97
HCV-related steatosis and risk of atherosclerosis 97
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 97
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 97
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 97
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 96
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 96
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 96
Viral Hepatitis C 96
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 96
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 95
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 95
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 95
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 94
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 94
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 94
Le infezioni cardiovascolari severe:patogeni emergenti e problematiche terapeutiche 94
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 94
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 94
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 93
Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp 93
Totale 11.149
Categoria #
all - tutte 137.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.655 0 0 0 0 0 34 429 357 16 414 307 98
2021/20222.572 144 9 32 60 879 22 29 67 110 220 212 788
2022/20235.182 462 88 63 392 679 405 17 334 2.492 43 103 104
2023/20241.971 149 69 76 174 718 241 23 63 8 22 131 297
2024/20256.167 26 76 86 130 989 944 801 498 787 1.031 466 333
2025/202611.131 758 862 1.128 1.231 1.956 5.196 0 0 0 0 0 0
Totale 35.263